
5d3 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma On October 8, 2025, the U.S. Food and Drug Administration approved cemiplimab as adjuvant therapy for adults with cutaneous squamous cell carcinoma (CSCC) at high ris
Medx weekly : Breast Cancer Insights Key Oncology Approvals And More
1665 Reached27 Comments
Similar Content

Single-incision Laparoscopy for Gastrostomy
408 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
863 Reached30 Comments15 Likes

Female with History of Amenorrhoea
3097 Reached10 Comments11 Likes

Role and Importance of DHA in Cognitive Development
524 Reached1 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1866 Reached17 Comments9 Likes